Literature DB >> 26125269

Bioinformatics analysis of gene expression profiles in hepatocellular carcinoma.

H Shangguan1, S-Y Tan, J-R Zhang.   

Abstract

OBJECTIVE: The aim of this study is to identify the gene expression profile specific to Hepatocellular Carcinoma (HCC) by comparing the different expression profiles in cirrhosis, dysplastic nodule (DN) and HCC tissues.
MATERIALS AND METHODS: The microarray data were downloaded from Gene Expression Omnibus (GEO) repository, involving 39 samples of normal liver tissues, 33 samples of cirrhosis, 17 samples of DNs and 286 samples of HCCs of different stages. Differential Expressed Genes (DEGs) of cirrhosis, DN and HCC liver tissues were analyzed by BRB-ArrayTool software; besides, the Gene Ontology (GO) analysis, Kyoto encyclopedia of Genes and Genomes (KEGG) and Biocarta pathway enrichment analysis were also performed. A protein-protein interaction (PPI) network was then constructed by STRING software using the genes in significantly different pathways. The resulting network was analyzed by Cytoscape software with CentiScaPe plugin to calculate the topological characteristics of the network and its individual node. Key genes were screened according to betweenness and degree of nodes.
RESULTS: few overlaps occurred in the GO categories of DEGs and in the gene sets from pathway analysis between HCCs, cirrhosis and DNs. DEGs in abnormal tissues were shown to be enriched in 29 KEGG pathways and 18 Biocarta pathways; and 43 key genes were identified to be involved in the maintenance of PPI network. In addition, the gene expression profiles were significantly different among cirrhosis, DN and HCC tissues.
CONCLUSIONS: The bioinformatic analysis of GEO datasets of HCC identified the functional gene sets associated with the genesis and development of HCC, and the key genes that were playing important roles in the maintenance of the molecular network for biological function specific to HCC. It provides the insights for more precise understandings of pathogenic mechanism, which will further expand the study on biomarker and targeted therapy of HCC.

Entities:  

Mesh:

Year:  2015        PMID: 26125269

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  16 in total

1.  Association between the expression of carbonic anhydrase II and clinicopathological features of hepatocellular carcinoma.

Authors:  Hui Zhang; Changhua Zhuo; Dong Zhou; Fan Zhang; Minyong Chen; Shaohua Xu; Zhaoshuo Chen
Journal:  Oncol Lett       Date:  2019-04-12       Impact factor: 2.967

2.  Prognostic gene biomarker identification in liver cancer by data mining.

Authors:  Gang Liu; Haitao Tang; Chen Li; Haiyan Zhen; Zhigang Zhang; Yongzhong Sha
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 3.  Why Are Omics Technologies Important to Understanding the Role of Nutrition in Inflammatory Bowel Diseases?

Authors:  Lynnette R Ferguson; Matthew P G Barnett
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

4.  NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings.

Authors:  Omer An; Giovanni M Dall'Olio; Thanos P Mourikis; Francesca D Ciccarelli
Journal:  Nucleic Acids Res       Date:  2015-10-29       Impact factor: 16.971

5.  Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis.

Authors:  Venkat Bhat; Sujitha Srinathan; Elisa Pasini; Marc Angeli; Emily Chen; Cristina Baciu; Mamatha Bhat
Journal:  World J Hepatol       Date:  2018-01-27

6.  Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.

Authors:  Bosheng He; Jianbing Yin; Shenchu Gong; Jinhua Gu; Jing Xiao; Weixiang Shi; Wenbin Ding; Ying He
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

7.  Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese.

Authors:  Yanhui Shi; Weiyu Zhai; Bin Wang; Dongmei Zhao; He Jin; Yuefei Wang; Jidong Zhang; Hongjun An; Zhongze Fu; Kun Zhao; Changzhu Lu
Journal:  Oncotarget       Date:  2016-12-06

8.  From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.

Authors:  Hong Yang; Xin Zhang; Xiao-Yong Cai; Dong-Yue Wen; Zhi-Hua Ye; Liang Liang; Lu Zhang; Han-Lin Wang; Gang Chen; Zhen-Bo Feng
Journal:  PeerJ       Date:  2017-03-14       Impact factor: 2.984

9.  Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.

Authors:  Lei Zhou; Yanyan Du; Lingqun Kong; Xingyuan Zhang; Qiangpu Chen
Journal:  Onco Targets Ther       Date:  2018-04-04       Impact factor: 4.147

10.  MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.

Authors:  Rong-Quan He; Xia Yang; Liang Liang; Gang Chen; Jie Ma
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.